Skip to main content
. 2017 Oct 8;7(10):e016546. doi: 10.1136/bmjopen-2017-016546

Table 2.

Differences in result measures in both study designs

Cross–sectional
(prevalence)
Retrospective cohort
(cumulative incidence)
Patients with adverse events (AEs) 1191/11379=10.47%
(95% CI 9.90% to 11.03%)
215/1088=19.76%
(95% CI 17.35% to 22.17%)
Total number of AEs 1349/11379=11.85%
(95% CI 11.26% to 12.46%)
314/1088=28.86%
(95% CI 26.12% to 31.61%)